Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 52


Distinct HIV discordancy patterns by epidemic size in stable sexual partnerships in sub-Saharan Africa.

Chemaitelly H, Cremin I, Shelton J, Hallett TB, Abu-Raddad LJ.

Sex Transm Infect. 2012 Feb;88(1):51-7. doi: 10.1136/sextrans-2011-050114.


Increased risk of HIV-1 transmission in pregnancy: a prospective study among African HIV-1-serodiscordant couples.

Mugo NR, Heffron R, Donnell D, Wald A, Were EO, Rees H, Celum C, Kiarie JN, Cohen CR, Kayintekore K, Baeten JM; Partners in Prevention HSV/HIV Transmission Study Team.

AIDS. 2011 Sep 24;25(15):1887-95. doi: 10.1097/QAD.0b013e32834a9338.


Prevention of HIV-1 infection with early antiretroviral therapy.

Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, Hakim JG, Kumwenda J, Grinsztejn B, Pilotto JH, Godbole SV, Mehendale S, Chariyalertsak S, Santos BR, Mayer KH, Hoffman IF, Eshleman SH, Piwowar-Manning E, Wang L, Makhema J, Mills LA, de Bruyn G, Sanne I, Eron J, Gallant J, Havlir D, Swindells S, Ribaudo H, Elharrar V, Burns D, Taha TE, Nielsen-Saines K, Celentano D, Essex M, Fleming TR; HPTN 052 Study Team.

N Engl J Med. 2011 Aug 11;365(6):493-505. doi: 10.1056/NEJMoa1105243. Epub 2011 Jul 18.


The role of acute and early HIV infection in the spread of HIV and implications for transmission prevention strategies in Lilongwe, Malawi: a modelling study.

Powers KA, Ghani AC, Miller WC, Hoffman IF, Pettifor AE, Kamanga G, Martinson FE, Cohen MS.

Lancet. 2011 Jul 16;378(9787):256-68. doi: 10.1016/S0140-6736(11)60842-8.


Towards an improved investment approach for an effective response to HIV/AIDS.

Schwartländer B, Stover J, Hallett T, Atun R, Avila C, Gouws E, Bartos M, Ghys PD, Opuni M, Barr D, Alsallaq R, Bollinger L, de Freitas M, Garnett G, Holmes C, Legins K, Pillay Y, Stanciole AE, McClure C, Hirnschall G, Laga M, Padian N; Investment Framework Study Group.

Lancet. 2011 Jun 11;377(9782):2031-41. doi: 10.1016/S0140-6736(11)60702-2.


Acute HIV-1 Infection.

Cohen MS, Shaw GM, McMichael AJ, Haynes BF.

N Engl J Med. 2011 May 19;364(20):1943-54. doi: 10.1056/NEJMra1011874. Review. No abstract available.


The cost of providing comprehensive HIV treatment in PEPFAR-supported programs.

Menzies NA, Berruti AA, Berzon R, Filler S, Ferris R, Ellerbrock TV, Blandford JM.

AIDS. 2011 Sep 10;25(14):1753-60. doi: 10.1097/QAD.0b013e3283463eec.


Ethical allocation of preexposure HIV prophylaxis.

Gostin LO, Kim SC.

JAMA. 2011 Jan 12;305(2):191-2. doi: 10.1001/jama.2010.1975. No abstract available.


HIV-1 transmission among HIV-1 discordant couples before and after the introduction of antiretroviral therapy.

Reynolds SJ, Makumbi F, Nakigozi G, Kagaayi J, Gray RH, Wawer M, Quinn TC, Serwadda D.

AIDS. 2011 Feb 20;25(4):473-7. doi: 10.1097/QAD.0b013e3283437c2b.


Derivation of parameters used in Spectrum for eligibility for antiretroviral therapy and survival on antiretroviral therapy.

Mahy M, Lewden C, Brinkhof MW, Dabis F, Tassie JM, Souteyrand Y, Stover J.

Sex Transm Infect. 2010 Dec;86 Suppl 2:ii28-34. doi: 10.1136/sti.2010.044255.


Preexposure chemoprophylaxis for HIV prevention in men who have sex with men.

Grant RM, Lama JR, Anderson PL, McMahan V, Liu AY, Vargas L, Goicochea P, Casapía M, Guanira-Carranza JV, Ramirez-Cardich ME, Montoya-Herrera O, Fernández T, Veloso VG, Buchbinder SP, Chariyalertsak S, Schechter M, Bekker LG, Mayer KH, Kallás EG, Amico KR, Mulligan K, Bushman LR, Hance RJ, Ganoza C, Defechereux P, Postle B, Wang F, McConnell JJ, Zheng JH, Lee J, Rooney JF, Jaffe HS, Martinez AI, Burns DN, Glidden DV; iPrEx Study Team.

N Engl J Med. 2010 Dec 30;363(27):2587-99. doi: 10.1056/NEJMoa1011205. Epub 2010 Nov 23.


Evaluating the cost-effectiveness of pre-exposure prophylaxis (PrEP) and its impact on HIV-1 transmission in South Africa.

Pretorius C, Stover J, Bollinger L, Bacaër N, Williams B.

PLoS One. 2010 Nov 5;5(11):e13646. doi: 10.1371/journal.pone.0013646.


Financing of HIV/AIDS programme scale-up in low-income and middle-income countries, 2009-31.

Hecht R, Stover J, Bollinger L, Muhib F, Case K, de Ferranti D.

Lancet. 2010 Oct 9;376(9748):1254-60. doi: 10.1016/S0140-6736(10)61255-X. Review.


HIV status in discordant couples in sub-Saharan Africa: a systematic review and meta-analysis.

Eyawo O, de Walque D, Ford N, Gakii G, Lester RT, Mills EJ.

Lancet Infect Dis. 2010 Nov;10(11):770-7. doi: 10.1016/S1473-3099(10)70189-4. Review.


Implementation science of pre-exposure prophylaxis: preparing for public use.

Underhill K, Operario D, Mimiaga MJ, Skeer MR, Mayer KH.

Curr HIV/AIDS Rep. 2010 Nov;7(4):210-9. doi: 10.1007/s11904-010-0062-4. Review.


Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women.

Abdool Karim Q, Abdool Karim SS, Frohlich JA, Grobler AC, Baxter C, Mansoor LE, Kharsany AB, Sibeko S, Mlisana KP, Omar Z, Gengiah TN, Maarschalk S, Arulappan N, Mlotshwa M, Morris L, Taylor D; CAPRISA 004 Trial Group.

Science. 2010 Sep 3;329(5996):1168-74. doi: 10.1126/science.1193748. Epub 2010 Jul 19. Erratum in: Science. 2011 Jul 29;333(6042):524.


Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study.

Montaner JS, Lima VD, Barrios R, Yip B, Wood E, Kerr T, Shannon K, Harrigan PR, Hogg RS, Daly P, Kendall P.

Lancet. 2010 Aug 14;376(9740):532-9. doi: 10.1016/S0140-6736(10)60936-1. Epub 2010 Jul 16.


Prognosis of patients with HIV-1 infection starting antiretroviral therapy in sub-Saharan Africa: a collaborative analysis of scale-up programmes.

May M, Boulle A, Phiri S, Messou E, Myer L, Wood R, Keiser O, Sterne JA, Dabis F, Egger M; IeDEA Southern Africa and West Africa.

Lancet. 2010 Aug 7;376(9739):449-57. doi: 10.1016/S0140-6736(10)60666-6. Epub 2010 Jul 15.


Planning for pre-exposure prophylaxis to prevent HIV transmission: challenges and opportunities.

Kim SC, Becker S, Dieffenbach C, Hanewall BS, Hankins C, Lo YR, Mellors JW, O'Reilly K, Paxton L, Roffenbender JS, Warren M, Piot P, Dybul MR.

J Int AIDS Soc. 2010 Jul 12;13:24. doi: 10.1186/1758-2652-13-24.

Supplemental Content

Support Center